These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

928 related articles for article (PubMed ID: 28551069)

  • 41. Measurement of ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapy.
    Modrak DE
    Methods Mol Med; 2005; 111():183-94. PubMed ID: 15911980
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sphingolipids in macroautophagy.
    Lavieu G; Scarlatti F; Sala G; Carpentier S; Levade T; Ghidoni R; Botti J; Codogno P
    Methods Mol Biol; 2008; 445():159-73. PubMed ID: 18425450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acid Ceramidase in Melanoma: EXPRESSION, LOCALIZATION, AND EFFECTS OF PHARMACOLOGICAL INHIBITION.
    Realini N; Palese F; Pizzirani D; Pontis S; Basit A; Bach A; Ganesan A; Piomelli D
    J Biol Chem; 2016 Jan; 291(5):2422-34. PubMed ID: 26553872
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer.
    Ruckhäberle E; Rody A; Engels K; Gaetje R; von Minckwitz G; Schiffmann S; Grösch S; Geisslinger G; Holtrich U; Karn T; Kaufmann M
    Breast Cancer Res Treat; 2008 Nov; 112(1):41-52. PubMed ID: 18058224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sphingolipid metabolism and its role in the skeletal tissues.
    Khavandgar Z; Murshed M
    Cell Mol Life Sci; 2015 Mar; 72(5):959-69. PubMed ID: 25424644
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ceramidases, roles in sphingolipid metabolism and in health and disease.
    Coant N; Sakamoto W; Mao C; Hannun YA
    Adv Biol Regul; 2017 Jan; 63():122-131. PubMed ID: 27771292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The compartmentalization and translocation of the sphingosine kinases: mechanisms and functions in cell signaling and sphingolipid metabolism.
    Siow D; Wattenberg B
    Crit Rev Biochem Mol Biol; 2011 Oct; 46(5):365-75. PubMed ID: 21864225
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sphingolipid metabolizing enzymes as novel therapeutic targets.
    Billich A; Baumruker T
    Subcell Biochem; 2008; 49():487-522. PubMed ID: 18751924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer treatment strategies targeting sphingolipid metabolism.
    Oskouian B; Saba JD
    Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy.
    Lee JY; Jin HK; Bae JS
    BMB Rep; 2020 Jan; 53(1):28-34. PubMed ID: 31818364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy.
    Huwiler A; Zangemeister-Wittke U
    Crit Rev Oncol Hematol; 2007 Aug; 63(2):150-9. PubMed ID: 17560117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Transcriptional regulation of sphingolipid metabolic enzymes].
    Murate T
    Seikagaku; 2007 Dec; 79(12):1139-43. PubMed ID: 18203454
    [No Abstract]   [Full Text] [Related]  

  • 53. Rewiring Endothelial Sphingolipid Metabolism to Favor S1P Over Ceramide Protects From Coronary Atherosclerosis.
    Manzo OL; Nour J; Sasset L; Marino A; Rubinelli L; Palikhe S; Smimmo M; Hu Y; Bucci MR; Borczuk A; Elemento O; Freed JK; Norata GD; Di Lorenzo A
    Circ Res; 2024 Apr; 134(8):990-1005. PubMed ID: 38456287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sphingosine kinase localization in the control of sphingolipid metabolism.
    Siow DL; Anderson CD; Berdyshev EV; Skobeleva A; Natarajan V; Pitson SM; Wattenberg BW
    Adv Enzyme Regul; 2011; 51(1):229-44. PubMed ID: 21075134
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of ceramide-metabolising enzymes in subcutaneous and intra-abdominal human adipose tissue.
    Kolak M; Gertow J; Westerbacka J; Summers SA; Liska J; Franco-Cereceda A; Orešič M; Yki-Järvinen H; Eriksson P; Fisher RM
    Lipids Health Dis; 2012 Sep; 11():115. PubMed ID: 22974251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes.
    Gencer EB; Ural AU; Avcu F; Baran Y
    Ann Hematol; 2011 Nov; 90(11):1265-75. PubMed ID: 21455605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A signaling cascade mediated by ceramide, src and PDGFRβ coordinates the activation of the redox-sensitive neutral sphingomyelinase-2 and sphingosine kinase-1.
    Cinq-Frais C; Coatrieux C; Grazide MH; Hannun YA; Nègre-Salvayre A; Salvayre R; Augé N
    Biochim Biophys Acta; 2013 Aug; 1831(8):1344-56. PubMed ID: 23651497
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enzymes of sphingolipid metabolism: from modular to integrative signaling.
    Hannun YA; Luberto C; Argraves KM
    Biochemistry; 2001 Apr; 40(16):4893-903. PubMed ID: 11305904
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications.
    Morad SA; Cabot MC
    Biochim Biophys Acta; 2015 Sep; 1851(9):1134-45. PubMed ID: 25964209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of inhibitors of key enzymes of sphingolipid metabolism on insulin-induced glucose uptake and glycogen synthesis in liver cells of old rats.
    Babenko NA; Kharchenko VS
    Biochemistry (Mosc); 2015 Jan; 80(1):104-12. PubMed ID: 25754045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.